Kala Bio, Inc. (KALA)
0.80
+0.03
(+3.91%)
USD |
NASDAQ |
Dec 11, 11:11
Kala Bio EPS Diluted (Quarterly): -1.074 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Q32 Bio, Inc. | -0.6036 |
| PharmaCyte Biotech, Inc. | -1.230 |
| Allogene Therapeutics, Inc. | -0.1864 |
| Akero Therapeutics, Inc. | -0.9946 |
| Belite Bio, Inc. | -0.6529 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.564M |
| Total Expenses (Quarterly) | 7.564M |
| Enterprise Value | 15.17M |
| Earnings Yield | -742.3% |
| Normalized Earnings Yield | -782.44 |